« Back
Home /
Medroxyprogesterone

Medroxyprogesterone

Manufacturer	MedChem Express
Category	Oncology Food Safety Hormones Inhibitors & Compound Libraries Small Molecules By Organ Breast Cancer
Type	Inhibitors
Specific against	other
Amount	10mM/1mL
Quantity options	100 mg 10mM/1mL 1 g 500 mg
Item no.	HY-B0648-10mM
CASRN	520-85-4
eClass 6.1	30220300
eClass 9.0	32160605
Available
Alias	17α-Hydroxy-6α-methylprogesterone; U8840
Purity	99.30
Product Description	Medroxyprogesterone (17α-Hydroxy-6α-methylprogesterone) is a synthetic human variant of progesterone that is a progesterone receptor agonist with oral activity. Medroxyprogesterone can induce cell proliferation through the PI3K/Akt signaling pathway. Medroxyprogesterone has an inhibitory effect on atherosclerosis in mice. The progesterone agonist activity of Medroxyprogesterone is less effective than Medroxyprogesterone acetate (HY-B0469)[1][2][3][4].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Neuroscience-Neuromodulation
MolecularWeight	344.49
Clinical_Information	Launched
Manufacturers Research Area	Endocrinology; Cancer
Solubility	DMSO : 50 mg/mL (ultrasonic)
Manufacturers Target	Progesterone Receptor
Pathway	Vitamin D Related/Nuclear Receptor

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10mM/1mL

available

Request delivery time